BNTX

BioNTech Share Price - BNTX

107.30
1.87 (1.77%)
Upgrade to Real-Time
Afterhours (Closed)
107.30
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
BioNTech SE BNTX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
1.87 1.77% 107.30 20:00:00
Open Price Low Price High Price Close Price Prev Close
104.50 104.315 108.48 108.44 105.43
Bid Price Ask Price Spread News
107.30 107.49 0.19 - 5
Trades Volume VWAP Dollar Volume Avg Volume
20,056 1,696,295  106.51  180,674,586 3,778,051
Last Trade Time Type Quantity Stock Price Currency
19:59:46 formt 199  107.30 USD

BioNTech Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 25.84B 240.79M 240.79M  121.85M  - -0.95 -48.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
-  - 0.00% - -

more financials information »

News BioNTech

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

BNTX Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.000.000.000.0000.000.0%
3 Years0.000.000.000.0000.000.0%
5 Years0.000.000.000.0000.000.0%

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and small-molecule immunomodulators. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab, and does not yet have any commercialized medicines.


Your Recent History
NASDAQ
BNTX
BioNTech
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.